Pathogenic factors in sepsis such as LPS, after binding to TLR4, result in dysregulated inflammatory responses through complex immune activation, so targeting immune activating responses that inhibit neuroinflammation may be protective against BBB disruption by sepsis (Hartz et al., 2006; Miao et al., 2021). Here, TLR4 is linked to Sepsis.